IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $39,000 | -54.7% | 10,600 | -31.6% | 0.00% | – |
Q1 2022 | $86,000 | -8.5% | 15,500 | 0.0% | 0.00% | – |
Q4 2021 | $94,000 | -37.3% | 15,500 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $150,000 | -32.1% | 15,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $221,000 | +22.8% | 15,500 | +103.9% | 0.00% | 0.0% |
Q1 2021 | $180,000 | – | 7,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |